{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:18:26Z","timestamp":1761920306068},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12883-017-0903-5","type":"journal-article","created":{"date-parts":[[2017,7,5]],"date-time":"2017-07-05T11:34:39Z","timestamp":1499254479000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Relationship between Azathioprine metabolites and therapeutic efficacy in Chinese patients with neuromyelitis optica spectrum disorders"],"prefix":"10.1186","volume":"17","author":[{"given":"Xindi","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shenghui","family":"Mei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoqing","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yonghong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhigang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinghu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,7,5]]},"reference":[{"key":"903_CR1","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","volume":"85","author":"DM Wingerchuk","year":"2015","unstructured":"Wingerchuk DM, Banwell B, Bennett JL, Cabre P, Carroll W, Chitnis T, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 2015;85:177\u201389.","journal-title":"Neurology"},{"key":"903_CR2","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/j.1468-1331.2010.03066.x","volume":"17","author":"J Sellner","year":"2010","unstructured":"Sellner J, Boggild M, Clanet M, Hintzen RQ, Illes Z, Montalban X, et al. EFNS guidelines on diagnosis and management of neuromyelitis optica. Eur J Neurol. 2010;17:1019\u201332.","journal-title":"Eur J Neurol"},{"key":"903_CR3","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1177\/1352458514525870","volume":"20","author":"L Elsone","year":"2014","unstructured":"Elsone L, Kitley J, Luppe S, Lythgoe D, Mutch K, Jacob S, et al. Long-term efficacy, tolerability and retention rate of azathioprine in 103 aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder patients: a multicentre retrospective observational study from the UK. Mult Scler. 2014;20:1533\u201340.","journal-title":"Mult Scler"},{"key":"903_CR4","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1212\/WNL.51.4.1219","volume":"51","author":"RN Mandler","year":"1998","unstructured":"Mandler RN, Ahmed W, Dencoff JE. Devic's neuromyelitis optica: a prospective study of seven patients treated with prednisone and azathioprine. Neurology. 1998;51:1219\u201320.","journal-title":"Neurology"},{"key":"903_CR5","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1212\/WNL.0b013e31822a2780","volume":"77","author":"C Costanzi","year":"2011","unstructured":"Costanzi C, Matiello M, Lucchinetti CF, Weinshenker BG, Pittock SJ, Mandrekar J, et al. Azathioprine: tolerability, efficacy, and predictors of benefit in neuromyelitis optica. Neurology. 2011;77:659\u201366.","journal-title":"Neurology"},{"key":"903_CR6","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.jocn.2015.01.028","volume":"22","author":"W Qiu","year":"2015","unstructured":"Qiu W, Kermode AG, Li R, Dai Y, Wang Y, Wang J, et al. Azathioprine plus corticosteroid treatment in Chinese patients with neuromyelitis optica. J Clin Neurosci. 2015;22:1178\u201382.","journal-title":"J Clin Neurosci"},{"key":"903_CR7","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/MIB.0000000000000197","volume":"21","author":"J Amin","year":"2015","unstructured":"Amin J, Huang B, Yoon J, Shih DQ. Update 2014: advances to optimize 6-mercaptopurine and azathioprine to reduce toxicity and improve efficacy in the management of IBD. Inflamm Bowel Dis. 2015;21:445\u201352.","journal-title":"Inflamm Bowel Dis"},{"key":"903_CR8","first-page":"Ra247","volume":"10","author":"CJ Cara","year":"2004","unstructured":"Cara CJ, Pena AS, Sans M, Rodrigo L, Guerrero-Esteo M, Hinojosa J, et al. Reviewing the mechanism of action of thiopurine drugs: towards a new paradigm in clinical practice. Med Sci Monit. 2004;10:Ra247\u201354.","journal-title":"Med Sci Monit"},{"key":"903_CR9","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s00228-008-0478-6","volume":"64","author":"S Sahasranaman","year":"2008","unstructured":"Sahasranaman S, Howard D, Roy S. Clinical pharmacology and pharmacogenetics of thiopurines. Eur J Clin Pharmacol. 2008;64:753\u201367.","journal-title":"Eur J Clin Pharmacol"},{"key":"903_CR10","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3389\/fendo.2012.00163","volume":"3","author":"C Fung","year":"2012","unstructured":"Fung C, Vaughn DJ, Mitra N, Ciosek SL, Vardhanabhuti S, Nathanson KL, et al. Chemotherapy refractory testicular germ cell tumor is associated with a variant in armadillo repeat gene deleted in Velco-cardio-facial syndrome (ARVCF). Front Endocrinol (Lausanne). 2012;3:163.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"903_CR11","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1016\/0006-2952(86)90623-4","volume":"35","author":"CR Fairchild","year":"1986","unstructured":"Fairchild CR, Maybaum J, Kennedy KA. Concurrent unilateral chromatid damage and DNA strand breakage in response to 6-thioguanine treatment. Biochem Pharmacol. 1986;35:3533\u201341.","journal-title":"Biochem Pharmacol"},{"key":"903_CR12","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1172\/JCI16432","volume":"111","author":"I Tiede","year":"2003","unstructured":"Tiede I, Fritz G, Strand S, Poppe D, Dvorsky R, Strand D, et al. CD28-dependent Rac1 activation is the molecular target of azathioprine in primary human CD4+ T lymphocytes. J Clin Invest. 2003;111:1133\u201345.","journal-title":"J Clin Invest"},{"key":"903_CR13","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/tpj.2014.47","volume":"14","author":"HF Burnett","year":"2014","unstructured":"Burnett HF, Tanoshima R, Chandranipapongse W, Madadi P, Ito S, Ungar WJ. Testing for thiopurine methyltransferase status for safe and effective thiopurine administration: a systematic review of clinical guidance documents. Pharmacogenomics J. 2014;14:493\u2013502.","journal-title":"Pharmacogenomics J"},{"key":"903_CR14","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1097\/01.fpc.0000174788.69991.6b","volume":"15","author":"OE Salavaggione","year":"2005","unstructured":"Salavaggione OE, Wang L, Wiepert M, Yee VC, Weinshilboum RM. Thiopurine S-methyltransferase pharmacogenetics: variant allele functional and comparative genomics. Pharmacogenet Genomics. 2005;15:801\u201315.","journal-title":"Pharmacogenet Genomics"},{"key":"903_CR15","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00008571-199902000-00006","volume":"9","author":"ES Collie-Duguid","year":"1999","unstructured":"Collie-Duguid ES, Pritchard SC, Powrie RH, Sludden J, Collier DA, Li T, et al. The frequency and distribution of thiopurine methyltransferase alleles in Caucasian and Asian populations. Pharmacogenetics. 1999;9:37\u201342.","journal-title":"Pharmacogenetics"},{"key":"903_CR16","first-page":"27","volume":"139","author":"G Umamaheswaran","year":"2014","unstructured":"Umamaheswaran G, Kumar DK, Adithan C. Distribution of genetic polymorphisms of genes encoding drug metabolizing enzymes & drug transporters - a review with Indian perspective. Indian J Med Res. 2014;139:27\u201365.","journal-title":"Indian J Med Res"},{"key":"903_CR17","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1007\/s00424-003-1107-y","volume":"447","author":"JH Gray","year":"2004","unstructured":"Gray JH, Owen RP, Giacomini KM. The concentrative nucleoside transporter family, SLC28. Pflugers Arch. 2004;447:728\u201334.","journal-title":"Pflugers Arch"},{"key":"903_CR18","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1096\/fj.08-113902","volume":"23","author":"E Errasti-Murugarren","year":"2009","unstructured":"Errasti-Murugarren E, Molina-Arcas M, Casado FJ, Pastor-Anglada M. A splice variant of the SLC28A3 gene encodes a novel human concentrative nucleoside transporter-3 (hCNT3) protein localized in the endoplasmic reticulum. FASEB J. 2009;23:172\u201382.","journal-title":"FASEB J"},{"key":"903_CR19","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/sj.tpj.6500303","volume":"5","author":"I Badagnani","year":"2005","unstructured":"Badagnani I, Chan W, Castro RA, Brett CM, Huang CC, Stryke D, et al. Functional analysis of genetic variants in the human concentrative nucleoside transporter 3 (CNT3; SLC28A3). Pharmacogenomics J. 2005;5:157\u201365.","journal-title":"Pharmacogenomics J"},{"key":"903_CR20","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.bbrc.2006.02.134","volume":"343","author":"AK Fotoohi","year":"2006","unstructured":"Fotoohi AK, Lindqvist M, Peterson C, Albertioni F. Involvement of the concentrative nucleoside transporter 3 and equilibrative nucleoside transporter 2 in the resistance of T-lymphoblastic cell lines to thiopurines. Biochem Biophys Res Commun. 2006;343:208\u201315.","journal-title":"Biochem Biophys Res Commun"},{"key":"903_CR21","doi-asserted-by":"publisher","unstructured":"Mei S, Li X, Gong X, Li X, Yang L, Zhou H, Liu Y, Zhou A, Zhu L, Zhang X et al. LC-MS\/MS analysis of erythrocyte thiopurine nucleotides and their association with genetic variants in patients with neuromyelitis optica spectrum disorders taking azathioprine. Ther Drug Monit 2016; doi: 10.1097\/FTD.0000000000000362 .","DOI":"10.1097\/FTD.0000000000000362"},{"key":"903_CR22","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1177\/1352458511412995","volume":"17","author":"IA Ketelslegers","year":"2011","unstructured":"Ketelslegers IA, Modderman PW, Vennegoor A, Killestein J, Hamann D, Hintzen RQ. Antibodies against aquaporin-4 in neuromyelitis optica: distinction between recurrent and monophasic patients. Mult Scler. 2011;17:1527\u201330.","journal-title":"Mult Scler"},{"key":"903_CR23","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jneuroim.2016.02.015","volume":"293","author":"W Rae","year":"2016","unstructured":"Rae W, Burke G, Pinto A. A study of the utility of azathioprine metabolite testing in myasthenia gravis. J Neuroimmunol. 2016;293:82\u20135.","journal-title":"J Neuroimmunol"},{"key":"903_CR24","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1177\/1352458507077189","volume":"13","author":"S Watanabe","year":"2007","unstructured":"Watanabe S, Misu T, Miyazawa I, Nakashima I, Shiga Y, Fujihara K, et al. Low-dose corticosteroids reduce relapses in neuromyelitis optica: a retrospective analysis. Mult Scler. 2007;13:968\u201374.","journal-title":"Mult Scler"},{"key":"903_CR25","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1126\/science.273.5278.1109","volume":"273","author":"PF Swann","year":"1996","unstructured":"Swann PF, Waters TR, Moulton DC, Xu YZ, Zheng Q, Edwards M, et al. Role of postreplicative DNA mismatch repair in the cytotoxic action of thioguanine. Science (New York, NY). 1996;273:1109\u201311.","journal-title":"Science (New York, NY)"},{"key":"903_CR26","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1126\/science.2649979","volume":"244","author":"GB Elion","year":"1989","unstructured":"Elion GB. The purine path to chemotherapy. Science (New York, NY). 1989;244:41\u20137.","journal-title":"Science (New York, NY)"},{"key":"903_CR27","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3390\/ijms17030273","volume":"17","author":"M Jasiak-Zatonska","year":"2016","unstructured":"Jasiak-Zatonska M, Kalinowska-Lyszczarz A, Michalak S, Kozubski W. The immunology of Neuromyelitis Optica-current knowledge, clinical implications, controversies and future perspectives. Int J Mol Sci. 2016;17:273.","journal-title":"Int J Mol Sci"},{"key":"903_CR28","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1365-2710.2006.00707.x","volume":"31","author":"HF Lu","year":"2006","unstructured":"Lu HF, Shih MC, Chang YS, Chang JY, Ko YC, Chang SJ, et al. Molecular analysis of thiopurine S-methyltransferase alleles in Taiwan aborigines and Taiwanese. J Clin Pharm Ther. 2006;31:93\u20138.","journal-title":"J Clin Pharm Ther"},{"key":"903_CR29","doi-asserted-by":"crossref","first-page":"6343","DOI":"10.1007\/s11033-012-1456-8","volume":"39","author":"G Umamaheswaran","year":"2012","unstructured":"Umamaheswaran G, Krishna Kumar D, Kayathiri D, Rajan S, Shewade DG, Dkhar SA, et al. Inter and intra-ethnic differences in the distribution of the molecular variants of TPMT, UGT1A1 and MDR1 genes in the south Indian population. Mol Biol Rep. 2012;39:6343\u201351.","journal-title":"Mol Biol Rep"},{"key":"903_CR30","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1136\/gut.49.5.665","volume":"49","author":"PW Lowry","year":"2001","unstructured":"Lowry PW, Franklin CL, Weaver AL, Pike MG, Mays DC, Tremaine WJ, et al. Measurement of thiopurine methyltransferase activity and azathioprine metabolites in patients with inflammatory bowel disease. Gut. 2001;49:665\u201370.","journal-title":"Gut"},{"key":"903_CR31","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1080\/15257770.2011.597372","volume":"30","author":"PX Fernandez-Calotti","year":"2011","unstructured":"Fernandez-Calotti PX, Colomer D, Pastor-Anglada M. Translocation of nucleoside analogs across the plasma membrane in hematologic malignancies. Nucleosides Nucleotides Nucleic Acids. 2011;30:1324\u201340.","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"903_CR32","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/sj.leu.2403582","volume":"19","author":"M Molina-Arcas","year":"2005","unstructured":"Molina-Arcas M, Marce S, Villamor N, Huber-Ruano I, Casado FJ, Bellosillo B, et al. Equilibrative nucleoside transporter-2 (hENT2) protein expression correlates with ex vivo sensitivity to fludarabine in chronic lymphocytic leukemia (CLL) cells. Leukemia. 2005;19:64\u20138.","journal-title":"Leukemia"},{"key":"903_CR33","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1124\/jpet.107.131482","volume":"324","author":"G Minuesa","year":"2008","unstructured":"Minuesa G, Purcet S, Erkizia I, Molina-Arcas M, Bofill M, Izquierdo-Useros N, et al. Expression and functionality of anti-human immunodeficiency virus and anticancer drug uptake transporters in immune cells. J Pharmacol Exp Ther. 2008;324:558\u201367.","journal-title":"J Pharmacol Exp Ther"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-017-0903-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,28]],"date-time":"2019-09-28T14:36:17Z","timestamp":1569681377000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-017-0903-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,5]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["903"],"URL":"https:\/\/doi.org\/10.1186\/s12883-017-0903-5","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,5]]},"article-number":"130"}}